Cargando…
2018–2019 Drug Updates in Solid Tumors
Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, an...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857315/ https://www.ncbi.nlm.nih.gov/pubmed/33598321 http://dx.doi.org/10.6004/jadpro.2020.11.3.8 |
_version_ | 1783646423593517056 |
---|---|
author | Barbour, Sally |
author_facet | Barbour, Sally |
author_sort | Barbour, Sally |
collection | PubMed |
description | Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management. |
format | Online Article Text |
id | pubmed-7857315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Harborside Press LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-78573152021-02-16 2018–2019 Drug Updates in Solid Tumors Barbour, Sally J Adv Pract Oncol Meeting Reports Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857315/ /pubmed/33598321 http://dx.doi.org/10.6004/jadpro.2020.11.3.8 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Reports Barbour, Sally 2018–2019 Drug Updates in Solid Tumors |
title | 2018–2019 Drug Updates in Solid Tumors |
title_full | 2018–2019 Drug Updates in Solid Tumors |
title_fullStr | 2018–2019 Drug Updates in Solid Tumors |
title_full_unstemmed | 2018–2019 Drug Updates in Solid Tumors |
title_short | 2018–2019 Drug Updates in Solid Tumors |
title_sort | 2018–2019 drug updates in solid tumors |
topic | Meeting Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857315/ https://www.ncbi.nlm.nih.gov/pubmed/33598321 http://dx.doi.org/10.6004/jadpro.2020.11.3.8 |
work_keys_str_mv | AT barboursally 20182019drugupdatesinsolidtumors |